[go: up one dir, main page]

RS49608B - Stabilizovane farmaceutske smeše na bazi hinupristina i dalfopristina i njihovo dobivanje - Google Patents

Stabilizovane farmaceutske smeše na bazi hinupristina i dalfopristina i njihovo dobivanje

Info

Publication number
RS49608B
RS49608B YUP-224/99A YU22499A RS49608B RS 49608 B RS49608 B RS 49608B YU 22499 A YU22499 A YU 22499A RS 49608 B RS49608 B RS 49608B
Authority
RS
Serbia
Prior art keywords
dalfoprisitne
quinupristine
preparation
base
pharmaceutical compositions
Prior art date
Application number
YUP-224/99A
Other languages
English (en)
Inventor
Jean-Paul Bounine
Guilaume Conrath
Original Assignee
Aventis Pharma S.A.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A., filed Critical Aventis Pharma S.A.,
Publication of YU22499A publication Critical patent/YU22499A/sh
Publication of RS49608B publication Critical patent/RS49608B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Stabilizovana farmaceutska smeša, na bazi kombinacije hinupristin/dalfopristin, naznačen time, što obuhvata najmanje stehiometrijsku količinu metansulfonske ili hlorovodonične kiseline i što je njena vrednost pH u intervalu od 3,5 do 5. Prijava sadrži još 12 patentnih zahteva.
YUP-224/99A 1996-11-19 1997-11-14 Stabilizovane farmaceutske smeše na bazi hinupristina i dalfopristina i njihovo dobivanje RS49608B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9614062A FR2755857B1 (fr) 1996-11-19 1996-11-19 Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation

Publications (2)

Publication Number Publication Date
YU22499A YU22499A (sh) 2002-03-18
RS49608B true RS49608B (sr) 2007-06-04

Family

ID=9497744

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-224/99A RS49608B (sr) 1996-11-19 1997-11-14 Stabilizovane farmaceutske smeše na bazi hinupristina i dalfopristina i njihovo dobivanje

Country Status (45)

Country Link
US (1) US5994338A (sr)
EP (1) EP0949923B1 (sr)
JP (1) JP4278115B2 (sr)
KR (1) KR100530836B1 (sr)
CN (1) CN1146417C (sr)
AP (1) AP998A (sr)
AR (1) AR008695A1 (sr)
AT (1) ATE223217T1 (sr)
AU (1) AU740291B2 (sr)
BG (1) BG63621B1 (sr)
BR (1) BR9713087A (sr)
CA (1) CA2271095C (sr)
CO (1) CO4910113A1 (sr)
CZ (1) CZ299913B6 (sr)
DE (1) DE69715247T2 (sr)
DK (1) DK0949923T3 (sr)
DZ (1) DZ2349A1 (sr)
EA (1) EA002025B1 (sr)
EE (1) EE03668B1 (sr)
ES (1) ES2179375T3 (sr)
FR (1) FR2755857B1 (sr)
HK (1) HK1022832A1 (sr)
HR (1) HRP970615B1 (sr)
HU (1) HUP9904327A3 (sr)
IL (2) IL129607A0 (sr)
IN (1) IN187038B (sr)
JO (1) JO1992B1 (sr)
MA (1) MA26448A1 (sr)
MY (1) MY123805A (sr)
NO (1) NO992399D0 (sr)
NZ (1) NZ334949A (sr)
OA (1) OA11047A (sr)
PE (1) PE13999A1 (sr)
PL (1) PL190164B1 (sr)
PT (1) PT949923E (sr)
RS (1) RS49608B (sr)
SA (1) SA97180645B1 (sr)
SK (1) SK284311B6 (sr)
TN (1) TNSN97184A1 (sr)
TR (1) TR199901096T2 (sr)
TW (1) TW474816B (sr)
UA (1) UA59376C2 (sr)
UY (1) UY24780A1 (sr)
WO (1) WO1998022107A1 (sr)
ZA (1) ZA9710435B (sr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772272B1 (fr) * 1997-12-16 2000-01-14 Rhone Poulenc Rorer Sa Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
TR200100841T2 (tr) * 1998-09-25 2002-01-21 Cubist Pharmaceuticals, Inc. Antibiyotiklerin kullanımı
CN100335122C (zh) * 1999-03-03 2007-09-05 伊莱利利公司 含有成胶束表面活性剂的棘白菌素药物制剂
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
US6119269A (en) * 1999-09-23 2000-09-19 Imler; Jack Fishing vest with removable storage container system
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
FR2812549B1 (fr) * 2000-08-03 2003-03-21 Aventis Pharma Sa Associations dalfopristine/quinupristine avec le cefpirome
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549065B1 (fr) * 1983-07-13 1985-10-25 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2576022B1 (fr) * 1985-01-11 1987-09-11 Rhone Poulenc Sante Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2599036B1 (fr) * 1986-05-22 1988-09-09 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
DE69715247D1 (de) 2002-10-10
HUP9904327A3 (en) 2002-03-28
EA002025B1 (ru) 2001-12-24
CZ174899A3 (cs) 1999-08-11
HRP970615B1 (en) 2002-12-31
EE9900127A (et) 1999-12-15
HK1022832A1 (en) 2000-08-25
EP0949923B1 (fr) 2002-09-04
PL190164B1 (pl) 2005-11-30
BG103412A (en) 2000-06-30
JP2001504475A (ja) 2001-04-03
CA2271095C (fr) 2004-08-03
AU740291B2 (en) 2001-11-01
MY123805A (en) 2006-06-30
PT949923E (pt) 2003-01-31
SA97180645B1 (ar) 2005-12-12
UA59376C2 (uk) 2003-09-15
AP998A (en) 2001-08-09
EE03668B1 (et) 2002-04-15
YU22499A (sh) 2002-03-18
NO992399L (no) 1999-05-19
CA2271095A1 (fr) 1998-05-28
SK284311B6 (sk) 2005-01-03
HRP970615A2 (en) 1998-08-31
OA11047A (fr) 2003-03-07
IN187038B (sr) 2001-12-29
EA199900479A1 (ru) 2000-02-28
IL129607A (en) 2006-08-20
IL129607A0 (en) 2000-02-29
JP4278115B2 (ja) 2009-06-10
FR2755857B1 (fr) 1998-12-24
MA26448A1 (fr) 2004-12-20
TW474816B (en) 2002-02-01
DK0949923T3 (da) 2002-12-23
ZA9710435B (en) 1998-06-10
CZ299913B6 (cs) 2008-12-29
KR100530836B1 (ko) 2005-11-23
ATE223217T1 (de) 2002-09-15
AR008695A1 (es) 2000-02-09
PE13999A1 (es) 1999-05-05
DE69715247T2 (de) 2003-04-30
CN1146417C (zh) 2004-04-21
TNSN97184A1 (fr) 2005-03-15
UY24780A1 (es) 2001-08-27
KR20000053343A (ko) 2000-08-25
WO1998022107A1 (fr) 1998-05-28
NZ334949A (en) 2000-12-22
TR199901096T2 (xx) 1999-07-21
EP0949923A1 (fr) 1999-10-20
SK66099A3 (en) 2000-01-18
DZ2349A1 (fr) 2002-12-28
ES2179375T3 (es) 2003-01-16
US5994338A (en) 1999-11-30
CN1233959A (zh) 1999-11-03
JO1992B1 (en) 1999-05-15
CO4910113A1 (es) 2000-04-24
FR2755857A1 (fr) 1998-05-22
AU5125698A (en) 1998-06-10
NO992399D0 (no) 1999-05-19
BG63621B1 (bg) 2002-07-31
BR9713087A (pt) 2000-03-28
HUP9904327A2 (hu) 2000-06-28

Similar Documents

Publication Publication Date Title
EE03741B1 (et) N-propargüül-1-aminoindaani R-enantiomeeri, sellesoolade ja kompositsioonide kasutamine
ATE312843T1 (de) Neues cyclosporin mit verbesserter wirkung
IT1276723B1 (it) Formulazioni di analoghi dell'insulina
MY115662A (en) Novel compounds with analgesic effect
IT9021795A0 (it) Composizioni farmaceutiche e cosmetiche depigmentanti a base di acido caffeico.
NZ510254A (en) Novel composition and use
IT8323205A0 (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
DE69400872D1 (de) Kraftstoffzusammensetzungen
DE69004219D1 (de) Zahnzementzusammensetzung.
RS49608B (sr) Stabilizovane farmaceutske smeše na bazi hinupristina i dalfopristina i njihovo dobivanje
IT1290797B1 (it) Composizioni farmaceutiche stabilizzate
ATE58838T1 (de) Mittel mit kontinuierlicher peptidfreisetzung.
NO942348L (no) Brennstoffsammensetninger
DE69307841D1 (de) Polyketon-Polymerzusammensetzung
ITRM920845A0 (it) Composizioni cementizie.
ITMI950961A0 (it) Composizioni farmaceutiche contenenti gemfibrozil
NO921807L (no) Brennstoffsammensetning
IT9019422A0 (it) Composizioni farmaceutiche ad attivita' depigmentante e "antiphotoaging"
ITMI913510A1 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
HU9502509D0 (en) Use of 1,4-dihydropyridine-3,5-dicarboxylic-acid-esters as active component of pharmaceutical compositions
FI101973B (fi) Kopolymeerikoostumuksia, jotka sisältävät kopolymeeriä ja yhtä tai use ampaa voitelevaa lisäainetta
FR2710673B1 (fr) Composition d'enduit de parement.
DE69129195D1 (de) Stabilisierte polymerzusammensetzungen
FR2686221B1 (fr) Compositions a base d'antiseptiques et leurs applications.
ITMI930453A1 (it) Composizione farmaceutica avente attivita' antiasmatica